Friday 6 November 2026 Export ADMA’s income statement to Excel — free account

ADMA Biologics Inc

ADMA Healthcare Biotechnology

ADMA Biologics Inc’s revenue for fiscal 2025 (year ended December 2025) was $510.2 million, up 19.6% from fiscal 2024.

Revenue: +5.12%
EPS: +46.7%
Free cash flow: +1,709.5%
Total debt: +140.5%

Quarter to September 2026, against a year earlier

12.78 0.43 −3.26%

Follow ADMA

Alert me

Market cap: $3.0B
P/E: 16.7×
Fwd P/E: 14.0×
Dividend yield: —
F-score: 5/9
Altman Z: 19.98
Beneish M: −0.17
Dividend safety: n/a

Overview

ADMA Biologics Inc (ADMA) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, ADMA Biologics Inc (ADMA) trades at a P/E ratio of 16.7×. Over the past ten years it has ranged from 0.0× (June 2024) to 134× (September 2024); the current reading is higher than 86% of that period. That is above the Biotechnology industry median of 10.3× and below the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ADMA/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="ADMA Biologics Inc P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ADMA/metrics/pe-ratio">ADMA Biologics Inc (ADMA) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	29.9×	46.46%
FY2024	20.4×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Sep 2026	12.7×	9.21%
Jun 2026	11.6×	(10.97%)
Mar 2026	13.1×	(56.33%)
Dec 2025	29.9×	77.45%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 134×

Ten-year median 0.0×

Current reading's percentile 86

Company	P/E ratio
PVLA Palvella Therapeutics, Inc. compare	n/m
PHVS Pharvaris N.V. compare	n/m
BHVN Biohaven Ltd. compare	n/m
VERA Vera Therapeutics, Inc. compare	n/m
CLDX Celldex Therapeutics, Inc. compare	n/m
IMNM Immunome, Inc. compare	n/m
AUPH Aurinia Pharmaceuticals Inc compare	6.8×
ADMA ADMA Biologics Inc	16.7×
VCEL Vericel Corporation compare	77.8×
Biotechnology industry median	10.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

ADMA Biologics Inc (ADMA) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ADMA

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ADMA

Stockrow Weekly